Relationships between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal

Tatiana M. Doberczak, Stephen R. Kandall, Patricia Friedmann

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Objective: To define the relationships between neonatal opiate withdrawal and drug-related factors such as maternal methadone dosage, maternal and neonatal plasma levels, and rate of decline of methadone in neonatal plasma. Methods: Twenty-one methadone-dependent women and their newborn infants were studied. Fourteen of the women used other illicit drugs. The severity of neonatal withdrawal was assessed with a standardized scoring system. Venous blood samples for methadone levels were collected from the mothers within 24 hours of delivery and from their newborns within 24 hours of birth and on day 3–4 of life. Results: The maternal methadone dosage at delivery correlated significantly with the maternal plasma level drawn at 16 hours postpartum (r = 0.512, P <.05), and the maternal methadone level in turn correlated significantly with the neonatal plasma methadone level on day 1 of life (r = 0.545, P <.05). A positive correlation was found between the severity of central nervous system signs of withdrawal and the rate of decline of the neonatal plasma methadone level from day 1 to day 4 of life (r = 0.550, P <.05). Conclusion: This spectrum of relationships supports the concept that careful reduction of the maternal methadone dosage during pregnancy under intensive medical and psychosocial surveillance may benefit the drug-exposed newborn infant clinically.

Original languageEnglish (US)
Pages (from-to)936-940
Number of pages5
JournalObstetrics and Gynecology
Volume81
Issue number6
StatePublished - 1993
Externally publishedYes

Fingerprint

Methadone
Mothers
Newborn Infant
Opiate Alkaloids
Street Drugs
Pharmaceutical Preparations
Postpartum Period
Central Nervous System
Parturition
Pregnancy

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Relationships between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. / Doberczak, Tatiana M.; Kandall, Stephen R.; Friedmann, Patricia.

In: Obstetrics and Gynecology, Vol. 81, No. 6, 1993, p. 936-940.

Research output: Contribution to journalArticle

@article{af1dec82b4274759b9858efbd9766867,
title = "Relationships between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal",
abstract = "Objective: To define the relationships between neonatal opiate withdrawal and drug-related factors such as maternal methadone dosage, maternal and neonatal plasma levels, and rate of decline of methadone in neonatal plasma. Methods: Twenty-one methadone-dependent women and their newborn infants were studied. Fourteen of the women used other illicit drugs. The severity of neonatal withdrawal was assessed with a standardized scoring system. Venous blood samples for methadone levels were collected from the mothers within 24 hours of delivery and from their newborns within 24 hours of birth and on day 3–4 of life. Results: The maternal methadone dosage at delivery correlated significantly with the maternal plasma level drawn at 16 hours postpartum (r = 0.512, P <.05), and the maternal methadone level in turn correlated significantly with the neonatal plasma methadone level on day 1 of life (r = 0.545, P <.05). A positive correlation was found between the severity of central nervous system signs of withdrawal and the rate of decline of the neonatal plasma methadone level from day 1 to day 4 of life (r = 0.550, P <.05). Conclusion: This spectrum of relationships supports the concept that careful reduction of the maternal methadone dosage during pregnancy under intensive medical and psychosocial surveillance may benefit the drug-exposed newborn infant clinically.",
author = "Doberczak, {Tatiana M.} and Kandall, {Stephen R.} and Patricia Friedmann",
year = "1993",
language = "English (US)",
volume = "81",
pages = "936--940",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Relationships between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal

AU - Doberczak, Tatiana M.

AU - Kandall, Stephen R.

AU - Friedmann, Patricia

PY - 1993

Y1 - 1993

N2 - Objective: To define the relationships between neonatal opiate withdrawal and drug-related factors such as maternal methadone dosage, maternal and neonatal plasma levels, and rate of decline of methadone in neonatal plasma. Methods: Twenty-one methadone-dependent women and their newborn infants were studied. Fourteen of the women used other illicit drugs. The severity of neonatal withdrawal was assessed with a standardized scoring system. Venous blood samples for methadone levels were collected from the mothers within 24 hours of delivery and from their newborns within 24 hours of birth and on day 3–4 of life. Results: The maternal methadone dosage at delivery correlated significantly with the maternal plasma level drawn at 16 hours postpartum (r = 0.512, P <.05), and the maternal methadone level in turn correlated significantly with the neonatal plasma methadone level on day 1 of life (r = 0.545, P <.05). A positive correlation was found between the severity of central nervous system signs of withdrawal and the rate of decline of the neonatal plasma methadone level from day 1 to day 4 of life (r = 0.550, P <.05). Conclusion: This spectrum of relationships supports the concept that careful reduction of the maternal methadone dosage during pregnancy under intensive medical and psychosocial surveillance may benefit the drug-exposed newborn infant clinically.

AB - Objective: To define the relationships between neonatal opiate withdrawal and drug-related factors such as maternal methadone dosage, maternal and neonatal plasma levels, and rate of decline of methadone in neonatal plasma. Methods: Twenty-one methadone-dependent women and their newborn infants were studied. Fourteen of the women used other illicit drugs. The severity of neonatal withdrawal was assessed with a standardized scoring system. Venous blood samples for methadone levels were collected from the mothers within 24 hours of delivery and from their newborns within 24 hours of birth and on day 3–4 of life. Results: The maternal methadone dosage at delivery correlated significantly with the maternal plasma level drawn at 16 hours postpartum (r = 0.512, P <.05), and the maternal methadone level in turn correlated significantly with the neonatal plasma methadone level on day 1 of life (r = 0.545, P <.05). A positive correlation was found between the severity of central nervous system signs of withdrawal and the rate of decline of the neonatal plasma methadone level from day 1 to day 4 of life (r = 0.550, P <.05). Conclusion: This spectrum of relationships supports the concept that careful reduction of the maternal methadone dosage during pregnancy under intensive medical and psychosocial surveillance may benefit the drug-exposed newborn infant clinically.

UR - http://www.scopus.com/inward/record.url?scp=0027336245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027336245&partnerID=8YFLogxK

M3 - Article

VL - 81

SP - 936

EP - 940

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 6

ER -